Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 89356 refers to the procedure of thawing cryopreserved oocytes, with each aliquot being treated individually. This process is a critical step in assisted reproductive technology, where oocytes that have been preserved through cryopreservation are prepared for use in fertility treatments. Cryopreservation involves freezing oocytes to preserve their viability for future use, and thawing is necessary to reactivate these cells for fertilization. During the thawing process, the oocytes are warmed using specific techniques designed to ensure their integrity and functionality. The cryoprotectant, a substance used to prevent ice crystal formation during freezing, must be carefully removed to avoid toxicity to the oocytes. This is achieved through a series of culture mediums that gradually decrease the concentration of the cryoprotectant. After thawing and the removal of the cryoprotectant, the oocytes are placed in a suitable culture medium and incubated for up to 48 hours. This incubation period allows for the assessment of the oocytes' viability, which is crucial for the success of subsequent assisted reproductive procedures. The thawing of oocytes is a vital component of fertility treatments, enabling the use of previously frozen eggs in conjunction with other reproductive technologies.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure described by CPT® Code 89356 is indicated for the thawing of cryopreserved oocytes in various assisted reproductive scenarios. The specific indications include:
The procedure for thawing cryopreserved oocytes involves several critical steps, which are detailed as follows:
After the thawing procedure, the oocytes are evaluated for viability, which is essential for the success of any further assisted reproductive techniques. If the oocytes are deemed viable, they may be used in conjunction with sperm for fertilization, leading to embryo development. It is important to monitor the oocytes closely during the incubation period to ensure optimal conditions for their development. Any additional assisted reproductive procedures, such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), will be performed based on the viability results and the specific treatment plan established by the healthcare provider.
| Short Descr | THAWING CRYOPRESRVED OOCYTE | Medium Descr | THAWING CRYOPRESERVED OOCYTES EACH ALIQUOT | Long Descr | Thawing of cryopreserved; oocytes, each aliquot | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | STV-Packaged Codes | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 2 | CCS Clinical Classification | 235 - Other Laboratory |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 2004-01-01 | Added | First appearance in code book in 2004. |
Get instant expert-level medical coding assistance.